U.S. Federal Trade Commission: In the matter of Teva Pharmaceutical Industries & Cephalon [decision & order]
MLex Summary: The Federal Trade Commission has issued its decision and order, conditionally approving the tie-up on the sale of the generic cancer pain drug to the branded drug Actiq and...To view the full article, register now.
Already a subscriber? Click here to view full article